HomeJANX • NASDAQ
add
Janux Therapeutics Inc
Previous close
$29.06
Day range
$28.26 - $29.17
Year range
$22.52 - $71.71
Market cap
1.71B USD
Avg Volume
975.31K
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
In the news
Financials
Income Statement
Revenue
Net income
| (USD) | Dec 2024info | Y/Y change |
|---|---|---|
Revenue | 0.00 | -100.00% |
Operating expense | 8.22M | 29.24% |
Net income | -20.22M | -71.93% |
Net profit margin | — | — |
Earnings per share | -0.36 | -44.00% |
EBITDA | -28.51M | -82.69% |
Effective tax rate | — | — |
Balance Sheet
Total assets
Total liabilities
| (USD) | Dec 2024info | Y/Y change |
|---|---|---|
Cash and short-term investments | 1.03B | 197.99% |
Total assets | 1.06B | 179.05% |
Total liabilities | 38.74M | 7.42% |
Total equity | 1.02B | — |
Shares outstanding | 59.11M | — |
Price to book | 1.68 | — |
Return on assets | -8.26% | — |
Return on capital | -8.41% | — |
Cash Flow
Net change in cash
| (USD) | Dec 2024info | Y/Y change |
|---|---|---|
Net income | -20.22M | -71.93% |
Cash from operations | -16.72M | -68.92% |
Cash from investing | 33.93M | 205.01% |
Cash from financing | 386.65M | 46,428.28% |
Net change in cash | 403.85M | 19,571.26% |
Free cash flow | -11.39M | -67.33% |
About
Founded
2017
Website
Employees
81
